$0.754
+0.003 (+0.44%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TCRX Prediction & Forecast by Similar Chart Analysis
Alphio's TCRX stock price prediction model matches the current TScan Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.74 (-1.51%). The 1-week path is $0.73 (-3.76%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy TScan Therapeutics Inc Stock?
TScan Therapeutics Inc (TCRX) is currently trading at $0.75, which is significantly lower than the analyst price target of $5, indicating potential upside. However, the stock has a low Relative Strength Index (RSI) of 38.43, suggesting it is nearing oversold conditions, but it has also seen a 56.94% decline over the past year, indicating ongoing challenges. The company reported a Q2 2026 revenue of $1.1 million, down from $3.1 million in Q2 2025, reflecting weak market demand. The main risk is the negative net income of -$30.36 million in Q2 2026, which highlights profitability concerns.
TCRX stock price ended at $0.75 on Friday, after rising +0.44%
TScan Therapeutics Inc (TCRX) last closed at $0.7535, gaining +0.44%. These facts feed the 1-day and 1-week TCRX price prediction above.
Forecast Drivers
TScan Therapeutics Inc (TCRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TCRX, ranked by similarity.
Seasonality analysis for TCRX
Historically the probability of a positive August return for TCRX is 20.63%. April offers the highest probability of a positive month at 64.06%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TCRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.39 | $1.49 | $1.73 | +97.42% |
| Sep 2026 | $0.94 | $1.46 | $1.61 | +93.95% |
| Oct 2026 | $1.26 | $1.77 | $2.18 | +135.05% |
| Nov 2026 | $1.76 | $2.10 | $2.47 | +178.41% |
| Dec 2026 | $1.62 | $2.10 | $2.70 | +178.41% |
In 2026, TScan Therapeutics Inc (TCRX) is projected to range from $0.94 to $2.70.
TScan Therapeutics Inc 2026 monthly forecast
In Aug 2026, TScan Therapeutics Inc is projected to average $1.49, with a low of $1.39 and high of $1.73.
In Sep 2026, TScan Therapeutics Inc is projected to average $1.46, with a low of $0.94 and high of $1.61.
In Oct 2026, TScan Therapeutics Inc is projected to average $1.77, with a low of $1.26 and high of $2.18.
In Nov 2026, TScan Therapeutics Inc is projected to average $2.10, with a low of $1.76 and high of $2.47.
In Dec 2026, TScan Therapeutics Inc is projected to average $2.10, with a low of $1.62 and high of $2.70.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.